Literature DB >> 12100993

A novel pH-sensitive liposome formulation containing oleyl alcohol.

Jennifer J Sudimack1, Wenjin Guo, Werner Tjarks, Robert J Lee.   

Abstract

pH-sensitive liposomes are designed to undergo acid-triggered destabilization. First generation pH-sensitive liposomes, based on the cone-shaped lipid dioleoylphosphatidylethanolamine (DOPE), have been shown to lose fusogenicity in the presence of serum. Here, we report the design and evaluation of novel serum-resistant pH-sensitive liposome formulations that are based on the composition of egg phosphatidylcholine (PC), cholesteryl hemisuccinate (CHEMS), oleyl alcohol (OAlc), and Tween-80 (T-80). When loaded with the fluorescent probe calcein, these liposomes exhibited excellent stability at pH 7.4 and underwent rapid destabilization upon acidification as shown by calcein dequenching and particle size increase. Adjusting the mole percentages of T-80 and OAlc in the formulation could regulate the stability and pH-sensitive properties of these liposomes. Liposomes with a higher T-80 content exhibited greater stability but were less sensitive to acid-induced destabilization. Meanwhile, formulations with a higher OAlc content exhibited greater content release in response to low pH. The pH-triggered liposomal destabilization did not produce membrane fusion according to an octadecylrhodamine B chloride (R(18)) lipid-mixing assay. Compared to DOPE-based pH-sensitive liposomes, the above formulations showed much better retention of their pH-sensitive properties in the presence of 10% serum. These liposomes were then evaluated for intracellular delivery of entrapped cytosine-beta-D-arabinofuranoside (araC) in KB human oral cancer cells, which have elevated folate receptor (FR) expression. The FR, which is amplified in many types of human tumors, has been shown to mediate the internalization of folate-derivatized liposomes into an acidic intracellular compartment. FR-targeted OAlc-based pH-sensitive liposomes, entrapping 200 mM araC, showed approximately 17-times greater FR-dependent cytotoxicity in KB cells compared to araC delivered via FR-targeted non-pH-sensitive liposomes. These data indicated that pH-sensitive liposomes based on OAlc, combined with FR-mediated targeting, are promising delivery vehicles for membrane impermeable therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100993     DOI: 10.1016/s0005-2736(02)00399-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.

Authors:  Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

2.  Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.

Authors:  Hongtao Xu; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2015-02-06       Impact factor: 4.200

3.  Calcein release from polymeric vesicles in blood plasma and PVA hydrogel.

Authors:  S Litvinchuk; Z Lu; P Rigler; T D Hirt; W Meier
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

4.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

Review 5.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

6.  Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery.

Authors:  Chenguang Zhou; Bo Yu; Xiaojuan Yang; Tianyao Huo; L James Lee; Rolf F Barth; Robert J Lee
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

7.  Acid-responsive nanospheres from an asparagine-derived amphiphile.

Authors:  Adelphe M Mfuh; Mathew P D Mahindaratne; Audrey E Yñigez-Gutierrez; Juan R Ramos Dominguez; Jefferson T Bedell; Carlos D Garcia; George R Negrete
Journal:  RSC Adv       Date:  2015       Impact factor: 3.361

Review 8.  Environmentally responsive peptides as anticancer drug carriers.

Authors:  Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal:  Adv Drug Deliv Rev       Date:  2009-07-20       Impact factor: 15.470

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 10.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.